Welcome to our dedicated page for Hercules Capital SEC filings (Ticker: HTGC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Hercules Capital, Inc. filings document the regulatory reporting of a specialty finance company that provides senior secured venture growth loans to technology and life sciences businesses. Its Form 8-K filings cover earnings releases, operating and financial condition updates, cash distribution declarations, executive leadership changes and related exhibits.
Proxy materials describe annual meeting matters, board governance, executive compensation and equity-award disclosures. The company’s filings also identify its NYSE-listed common stock under HTGC and its 6.25% Notes due 2033 under HCXY, tying capital-structure disclosures to both equity and debt securities.
Hercules Capital held its 2025 Annual Meeting of Stockholders on June 18, 2025, where shareholders voted on four key proposals. With 175,420,455 shares eligible to vote, the results were:
- Board Elections: Scott Bluestein, Wade Loo, and DeAnne Aguirre were elected as Class III directors until 2028, with Bluestein receiving the strongest support (63.7M votes)
- Executive Compensation: Shareholders approved the named executive officer compensation with 56.1M votes in favor
- Below NAV Share Issuance: The proposal to authorize share sales below NAV was NOT approved, receiving insufficient support with 52.6M votes in favor
- Auditor Appointment: PricewaterhouseCoopers LLP was ratified as independent public accountant for FY2025 with overwhelming support (124.6M votes)
The failed below-NAV authorization proposal represents a significant outcome that could limit the company's capital raising flexibility in the coming year.